J.B. Pharma
Mumbai, India· Est.
Indian pharma delivering affordable small‑molecule medicines across 20 therapeutic categories.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian pharma delivering affordable small‑molecule medicines across 20 therapeutic categories.
CardiovascularMetabolicGastroenterologyNephrologyPain ManagementRespiratoryGynaecologyDiabetesDermatologyVirologyNicotine Replacement Therapy
Technology Platform
Robust small‑molecule formulation and manufacturing platform with advanced dosage‑form capabilities, supported by US‑FDA, EU‑GMP and SAHPRA‑accredited facilities.
Opportunities
Expansion of export markets, contract manufacturing services, and development of specialty small‑molecule dosage forms.
Risk Factors
Price pressure in the generic segment, regulatory compliance across multiple jurisdictions, and competition from larger multinational firms.
Competitive Landscape
Competes with domestic generics leaders and global players; differentiation stems from its extensive dosage‑form expertise and wide regulatory accreditations.